Thus, the anti-lung cancer effects of Scabraside B oppose its tendency towards EPCR in the in silico condition, and the affinity of this compound towards receptors that trigger apoptosis in lung cancer cells is more dominant. The gene discussed is PROCR; the disease is lung carcinoma.